Lancet
-
Total joint replacements for end-stage osteoarthritis of the hip and knee are cost-effective and demonstrate significant clinical improvement. However, robust population based lifetime-risk data for implant revision are not available to aid patient decision making, which is a particular problem in young patient groups deciding on best-timing for surgery. ⋯ Oxford Musculoskeletal Biomedical Research Unit, National Institute for Health Research.